IL6 and B-cell chronic lymphocytic leukemia: Altogether, these data suggest that the increased A2M production by CLL B-lymphocytes probably depends both on factor/s that exist in the CLL serum (such as IL-6-type cytokines), as well as on the capability of the cells to respond to these factors, an ability that appears to exist in both CLL and NC B-lymphocytes.